Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.
about
MicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesMicroRNA-mediated interactions between host and hepatitis C virusmiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimirThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateMiR-122 in hepatitis B virus and hepatitis C virus dual infectionRole of microRNAs in hepatocellular carcinoma: a clinical perspectiveHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesMiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinomaChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data.Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway.Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma developmentCirculating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis.MicroRNA-22 can reduce parathymosin expression in transdifferentiated hepatocytesInhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α.MicroRNA-122 down-regulation is involved in phenobarbital-mediated activation of the constitutive androstane receptor.MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.Differential temporal expression of milk miRNA during the lactation cycle of the marsupial tammar wallaby (Macropus eugenii)Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancersIntegrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profilingModulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma.Understanding cooperativity of microRNAs via microRNA association networks.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway.Transcription factor binding sites are highly enriched within microRNA precursor sequences.Hepato-specific microRNA-122 facilitates accumulation of newly synthesized miRNA through regulating PRKRA.MicroRNA-Sequence Profiling Reveals Novel Osmoregulatory MicroRNA Expression Patterns in Catadromous Eel Anguilla marmorata.MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.Orchestrating liver development.Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate CellsDevelopment and distribution of neuronal cilia in mouse neocortexCross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver.Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2.Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancerCD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Cell-free Circulating miRNA Biomarkers in CancerGα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction
P2860
Q26750448-EBB11E04-6EE9-4E9A-9CB6-30112D605C6CQ26773254-21B524B2-666E-42ED-83C3-8254653B866EQ26991956-64A100F9-BF64-4C09-8897-2A111DA24EBDQ27003050-642E1E98-4745-464F-BE54-47CDBC2B6874Q27008894-B5DBBC55-8BBC-4343-B20C-C4B0332B71E8Q27014034-403F9F0C-22B8-4B52-B76C-C0FB38225D0DQ27024630-99121B53-4774-4F62-8697-14394B781CA1Q28658442-5988480F-8DCE-49D3-BFA1-39CF47D2A98CQ30577864-FA58D4C0-CE0D-4EA8-8D7F-D9C73C848767Q33717796-9A12990B-F81A-49CE-B4CE-00C820E3183EQ33988586-1D8EA314-FCF5-463B-A864-D93CD362580CQ34009053-85217336-5949-4D09-B1D9-A7DC76449D32Q34110794-5F5F13F0-D377-4402-A235-7AE44E2AE25FQ34228326-6EF6690B-6388-432F-8009-3B6C852CBFACQ34305346-C87145B5-37E6-4444-BBCC-CFAB4390F2DAQ34345924-AA226E0F-6130-4C66-B174-ECF9288EF256Q34442762-592C3258-B8B8-4843-BF20-51451A7C1419Q34586669-3874D47F-AF5D-4FB1-BB3A-5CDC5E31D3B8Q34958488-798E0AC3-D6E7-4B8F-986B-2A1AFC480CAEQ35079974-39D3EE69-0F18-4270-B3F1-B84BA50AD873Q35092970-C5199CE4-7EDA-4041-BE0A-95D34C29C782Q35095232-C382F267-3296-4CCE-BDF0-A87531D42E82Q35098185-52A9E71E-1485-4A2F-A8CA-48AA32DBE16BQ35343911-822CE23A-BD54-4A4C-83D0-52C8F5FEB560Q35550188-919311B7-E077-4E2D-BF80-860E54EF328EQ35619283-70DE5912-66BC-4555-9FEA-B0E6B50B1C52Q35672188-6D3FFF66-B6E0-4B1F-8577-A02A404428ADQ35753536-EE36597E-A181-4CBB-B5FD-02AD3DF7A07FQ35760644-82A35426-2B74-45A1-990B-9B5C147B9F3AQ35791195-C43B331F-19E8-4810-ABDA-3F6FF18A51F0Q35801944-646BF8B8-3B27-4E97-BA3A-39972902294FQ35861037-D7C35C94-D656-45F4-A74A-B7E59296BBE6Q35887451-72B26CED-9A97-4AA9-85C6-FD3EDEC9E8D8Q36004102-1804F5EC-E79A-4DF9-90AB-863E690706BEQ36065720-DF3A7D50-6211-41BA-B219-6392CCBD2EEBQ36213198-54600BCB-E0D6-4039-AE3B-8DFD9597D858Q36242193-BE7B0D75-444F-4D55-A6C0-945C02782392Q36253614-CCF119F7-B590-4AD2-B91C-F4F489A9A697Q36316601-C77206BF-DBFF-45A8-8CCC-17766220322CQ36326323-8C55395A-9224-47E9-B682-875761384496
P2860
Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Liver-enriched transcription f ...... UTL1 during liver development.
@ast
Liver-enriched transcription f ...... UTL1 during liver development.
@en
Liver-enriched transcription f ...... UTL1 during liver development.
@nl
type
label
Liver-enriched transcription f ...... UTL1 during liver development.
@ast
Liver-enriched transcription f ...... UTL1 during liver development.
@en
Liver-enriched transcription f ...... UTL1 during liver development.
@nl
prefLabel
Liver-enriched transcription f ...... UTL1 during liver development.
@ast
Liver-enriched transcription f ...... UTL1 during liver development.
@en
Liver-enriched transcription f ...... UTL1 during liver development.
@nl
P2093
P50
P356
P1433
P1476
Liver-enriched transcription f ...... CUTL1 during liver development
@en
P2093
Jie-Hua He
Qian-Qian Zhang
Yue-Qin Chen
Zhen-Dong Xiao
P304
P356
10.1002/HEP.23818
P407
P577
2010-10-01T00:00:00Z